This topic contains a solution. Click here to go to the answer

Author Question: A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive ... (Read 57 times)

james9437

  • Hero Member
  • *****
  • Posts: 568
A patient will begin using a transdermal preparation of a muscarinic antagonist for overactive bladder (OAB).
 
  The nurse teaches the patient what to do if side effects occur. Which statement by the patient indicates the need for further teaching?
  a. I can use sugar-free gum for dry mouth.
  b. I may need laxatives for constipation.
  c. I should keep the site covered to prevent other people from getting the medicine.
  d. I will take Benadryl for any itching caused by a local reaction to the patch.

Question 2

An older adult patient who lives alone and is somewhat forgetful has an overactive bladder and reports occasional constipation. Which treatment will the nurse anticipate for this patient?
 
  a. Behavioral therapy
  b. Oxybutynin (Ditropan XL) extended-release tablets
  c. Oxybutynin (Oxytrol) transdermal patch
  d. Percutaneous tibial nerve stimulation (PTNS)



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

brittiany.barnes

  • Sr. Member
  • ****
  • Posts: 321
Answer to Question 1

ANS: D
Benadryl is an antihistamine, and even though it is not classified as a muscarinic antagonist, it has anticholinergic effects. Giving it with a muscarinic antagonist greatly enhances these effects, so it should not be used. Muscarinic antagonists cause dry mouth, and patients should be taught to use sugar-free gum or candies to help with this. Muscarinic antagonists can cause constipation, and laxatives may be used. Medication applied topically can be transferred to others who come in contact with the skin, so the site should be covered.

Answer to Question 2

ANS: C
The transdermal patch is applied weekly and may be the best option for a patient who is more likely to forget to take a daily medication. The transdermal preparation has fewer side effects than the systemic dose so is less likely to increase this patient's constipation. Behavioral therapy should be tried first in patients who can participate. However, it is not the best option for a forgetful patient who lives alone, because it requires scheduled voiding and timing of fluid intake. The extended-release tablets must be given daily, and this patient may not remember to take them. PTNS is used after behavioral and drug therapies have failed.




james9437

  • Member
  • Posts: 568
Reply 2 on: Jul 23, 2018
Excellent


aruss1303

  • Member
  • Posts: 314
Reply 3 on: Yesterday
Great answer, keep it coming :)

 

Did you know?

Disorders that may affect pharmacodynamics include genetic mutations, malnutrition, thyrotoxicosis, myasthenia gravis, Parkinson's disease, and certain forms of insulin-resistant diabetes mellitus.

Did you know?

The lipid bilayer is made of phospholipids. They are arranged in a double layer because one of their ends is attracted to water while the other is repelled by water.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

The effects of organophosphate poisoning are referred to by using the abbreviations “SLUD” or “SLUDGE,” It stands for: salivation, lacrimation, urination, defecation, GI upset, and emesis.

Did you know?

When Gabriel Fahrenheit invented the first mercury thermometer, he called "zero degrees" the lowest temperature he was able to attain with a mixture of ice and salt. For the upper point of his scale, he used 96°, which he measured as normal human body temperature (we know it to be 98.6° today because of more accurate thermometers).

For a complete list of videos, visit our video library